NCT02319239
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
- Locations
-
- Tampere University Hospital Tampere, Finland
Clinical trial condition
Genital Neoplasms, Male
Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.
23 public trials
3 recruiting studies
Genital Neoplasms, Male trial results
NCT03077659
- Conditions
- Adenocarcinoma of the Prostate, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- University of Southern California Los Angeles, California, United States
NCT01310894
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Dept. of Urology-University Hospitals Leuven Leuven, Belgium
- Department of Urology-Tampere University Hospital- Tampere, Finland
- Service d'Urologie - Centre Hospitalier Universitaire d'Angers Angers, France
- CHRU Hopital Jean Minjoz Besançon, France
NCT01316458
- Conditions
- Abdominal Neoplasms, Antineoplastic Agents, Female Urogenital Diseases, +14 more
- Locations
-
- Novartis Investigative Site Aachen, Germany
- Novarts Investigative Site Berlin, Germany
- Novartis Investigative Site Bonn, Germany
- Novartis Investigative Site Borken, Germany
NCT01431391
- Conditions
- Adenocarcinoma, Carcinoma, Female Urogenital Diseases, +16 more
- Locations
-
- Urology Center of Alabama Homewood, Alabama, United States
- University of California San Diego / Moores Cancer Center La Jolla, California, United States
- Keck Hospital of USC Los Angeles, California, United States
- LAC + USC Medical Center Los Angeles, California, United States
NCT00707356
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- University Health Network-Princess Margaret Hospital Toronto, Canada
- Centre Hospitalier Universitaire Angers, France
- Hôpital Bocage-CHU Dijon, France
- Hôpital Claude Huriez Lille, France
Completed
Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer
NCT01875393
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Hospital General Tlahuac Mexico City, Mexico
- Pan-American Medical Research Institute (PAMRI) then moved to Consultario del Dr Rodriguez Panama City, Panama
- Hospital Nacional Cayetano Heredia San Martín de Porres, Peru
NCT00975429
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Centre Hospitalier Universitaire (CHU) Angers, France
- Hôpital Claude Huriez Lille, France
- Institut Mutualiste Montsouris(IMM) Paris, France
- Catharina Ziekenhuis Eindhoven, Netherlands
NCT00749502
- Conditions
- Adnexal Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +38 more
- Locations
-
Not specified
Active, Not Recruiting
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
NCT05067140
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
- Locations
-
- Clinical Trial Site Duarte, California, United States
- Clinical Trial Site Fresno, California, United States
- Clinical Trial Site La Jolla, California, United States
- Clinical Trial Site Orange, California, United States